Procter & Gamble Company (The) $PG Stock Position Boosted by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D grew its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.6% during the third quarter, Holdings Channel reports. The institutional investor owned 826,698 shares of the company’s stock after acquiring an additional 28,692 shares during the period. Procter & Gamble makes up about 0.5% of State of New Jersey Common Pension Fund D’s holdings, making the stock its 29th largest position. State of New Jersey Common Pension Fund D’s holdings in Procter & Gamble were worth $127,022,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Czech National Bank boosted its position in shares of Procter & Gamble by 3.8% in the 3rd quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after purchasing an additional 21,825 shares during the period. Westerkirk Capital Inc. purchased a new stake in Procter & Gamble during the second quarter valued at about $4,796,000. Vega Investment Solutions increased its position in shares of Procter & Gamble by 1.3% in the second quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after acquiring an additional 8,500 shares in the last quarter. Caliber Wealth Management LLC KS raised its holdings in shares of Procter & Gamble by 36.2% during the second quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock valued at $2,836,000 after acquiring an additional 4,730 shares during the period. Finally, Jump Financial LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $7,891,000. Institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In related news, insider Marc S. Pritchard sold 95,903 shares of the company’s stock in a transaction on Friday, January 23rd. The shares were sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the sale, the insider directly owned 182,607 shares of the company’s stock, valued at approximately $27,601,048.05. This represents a 34.43% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 12,827 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the sale, the insider owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This trade represents a 50.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 326,091 shares of company stock worth $51,795,360. 0.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on PG shares. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday, December 8th. Wells Fargo & Company upped their price target on Procter & Gamble from $158.00 to $165.00 and gave the company an “overweight” rating in a research report on Friday, January 23rd. UBS Group lifted their target price on Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a research note on Friday, January 23rd. Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Finally, Barclays set a $155.00 price objective on shares of Procter & Gamble in a research note on Friday, January 16th. Thirteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $167.67.

Check Out Our Latest Research Report on Procter & Gamble

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Modest fundamental support from recent results — P&G posted a slight EPS beat in its most recent quarter and set FY?2026 EPS guidance in the 6.83–7.09 range, which largely aligns with Street expectations and supports the stock’s valuation relative to peers. MarketBeat PG Summary
  • Neutral Sentiment: Brand/marketing update — P&G’s Native brand released a feature?length “microsoap” series as a marketing push; positive for brand engagement but unlikely to move near?term earnings materially. PR Newswire: Native microsoap launch
  • Neutral Sentiment: Analyst commentary on valuation and headwinds — Recent pieces note a YTD rally under new CEO but warn premium valuation, tariff pressures and margin squeeze could limit upside; useful context for positioning but not immediate catalysts. Zacks: Time to Buy or Wait?
  • Neutral Sentiment: Macro/competitive note — Coverage noting P&G’s YTD rally but that it lags some rivals and faces tariff challenges; informative for relative performance analysis. 247WallSt: Rallies Under New CEO
  • Negative Sentiment: Large insider selling — Multiple senior insiders disclosed sizable sales over Feb 11–12: CEO Gary Coombe sold ~36,093 shares (~$5.86M) and Chairman Jon Moeller reported sales totaling ~173,268 shares (two filings) worth tens of millions; another insider sold ~12,827 shares. Heavy insider selling can be interpreted as a near?term negative signal for sentiment/liquidity. SEC filings: Coombe Form 4 Moeller Form 4 (both) Purushothaman Form 4
  • Negative Sentiment: Regulatory risk in Italy — Italy’s competition authority opened an investigation into allegedly misleading advertising for a P&G epilator product; potential reputational, remediation or fines risk depending on outcome. Reuters: Italy probe

Procter & Gamble Price Performance

Shares of PG opened at $160.11 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The firm has a market cap of $372.09 billion, a PE ratio of 23.72, a PEG ratio of 5.32 and a beta of 0.38. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $179.99. The firm’s 50 day moving average price is $147.14 and its 200 day moving average price is $150.42.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Friday, January 23rd will be paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 62.67%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.